Polar Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $28.1M | Sell |
|
|||||
|
2020
Q2 | $31.3M | Buy |
|
|||||
|
2020
Q1 | $295K | Sell |
|
|||||
|
2019
Q4 | $12.1M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $39.2M | Buy |
|
|||||
|
2017
Q2 | $34.2M | Hold |
|
|||||
|
2017
Q1 | $27M | Hold |
|
|||||
|
2016
Q4 | $26.8M | Sell |
|
|||||
|
2016
Q3 | $21.4M | Buy |
|
|||||
|
2016
Q2 | $15.9M | Sell |
|
|||||
|
2016
Q1 | $20.7M | Hold |
|
|||||
|
2015
Q4 | $40.4M | Sell |
|
|||||
|
2015
Q3 | $35.2M | Buy |
|
|||||
|
2015
Q2 | $36.1M | Buy |
|
|||||
|
2015
Q1 | $23M | Hold |
|
|||||
|
2014
Q4 | $18.8M | Buy |
|
|||||
|
2014
Q3 | $13.3M | Buy |
|
|||||
|
2014
Q2 | $19.6M | Buy |
|
|||||
|
2014
Q1 | $7.79M | Buy |
|